Home » ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
Research and development biotechnology company ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. announced that it has recently responded to a Request for Information (RFI) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense for Therapeutic Countermeasures against CDC Category A and B Threat Agents.
PR Newswire
Upcoming Events
-
07May
-
14May
-
30May